Effects of dexmedetomidine postoperative anagesia on porioperative celluar immune function in patients after gynecological laparoscopy

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15007042

Enrollment

Unknown

Registered

2015-09-07

Start date

2015-09-14

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecology tumor

Interventions

D group:Dexmedetomidine

Fentanyl group:Fentanyl

D + F:Dex and F

C :Saline

Eligibility

Sex/Gender

Female

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: The gynecological tumor patients , undergoing elective laparoscopy will be enrolled the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria included body mass index>30, cardiovascular, respiratory or neurologic disease (especially bradycardia with cardiac conduction or rhythm abnormalities), analgesics intake, history of substance abuse, any conversion to laparotomy reful to participate in the follow-up assessment.

Design outcomes

Primary

Measure	Time frame
Immunological factor;celluar factor;Numeric rating scale;	—

Countries

China

Contacts

Public ContactWang Xiuqin

jasmine75@163.com+86 13665416586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026